TMBIM4 and Sepsis: The medication has also been shown to affect the sigma-1 receptor (S1R) in the endoplasmic reticulum (ER), which acts as a calcium signaling pathway regulator [3,4]. In 2019, data from mouse model research revealed that S1R agonists could be therapeutically effective in treating inflammation and sepsis [5].